Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn E Hacker

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Targeted Oncology|July 21, 2010
Emerging molecular classification in renal cell carcinoma: implications for drug developmentKathryn E Hacker, W Kimryn Rathmell
Surgical Oncology Clinics of North America|September 15, 2018
Engaging Stakeholders and Patient PartnersKathryn E Hacker, Angela B Smith
Plos One|November 26, 2008
VHL type 2B mutations retain VBC complex form and functionKathryn E Hacker, Caroline Martz Lee, W Kimryn Rathmell
Molecular Oncology|July 19, 2011
Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinomaBrian L Teng, Kathryn E Hacker, Shufen Chen, et al.
European Urology|October 28, 2011
Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biologyA Rose Brannon, Scott M Haake, Kathryn E Hacker, et al.
The Journal of Sexual Medicine|October 16, 2021
Factors Impacting Postoperative Opioid Use Among Patients Undergoing Implantation of Inflatable Penile ProsthesisMark E Ehlers, Charan S Mohan, Jason P Akerman, et al.
Urology|January 16, 2017
Detection of Upper Tract Urothelial Malignancies by Computed Tomography Urography in Patients Referred for Hematuria at a Large Tertiary Referral CenterClayton W Commander, David C Johnson, Mathew C Raynor, et al.
Gastrointestinal Cancer : Targets and Therapy|April 7, 2015
Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN lossAdam B Sendor, Kathryn E Hacker, Shufen Chen, et al.
The Journal of Biological Chemistry|July 30, 2013
Receptor tyrosine kinase-like orphan receptor 2 (Ror2) expression creates a poised state of Wnt signaling in renal cancerNeal R Rasmussen, Tricia M Wright, Samira A Brooks, et al.
The Journal of Biological Chemistry|August 17, 2016
Structure/Function Analysis of Recurrent Mutations in SETD2 Protein Reveals a Critical and Conserved Role for a SET Domain Residue in Maintaining Protein Stability and Histone H3 Lys-36 TrimethylationKathryn E Hacker, Catherine C Fahey, Stephen A Shinsky, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Targeted Oncology|July 21, 2010
Emerging molecular classification in renal cell carcinoma: implications for drug developmentKathryn E Hacker, W Kimryn Rathmell
Surgical Oncology Clinics of North America|September 15, 2018
Engaging Stakeholders and Patient PartnersKathryn E Hacker, Angela B Smith
Plos One|November 26, 2008
VHL type 2B mutations retain VBC complex form and functionKathryn E Hacker, Caroline Martz Lee, W Kimryn Rathmell
Molecular Oncology|July 19, 2011
Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinomaBrian L Teng, Kathryn E Hacker, Shufen Chen, et al.
European Urology|October 28, 2011
Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biologyA Rose Brannon, Scott M Haake, Kathryn E Hacker, et al.
The Journal of Sexual Medicine|October 16, 2021
Factors Impacting Postoperative Opioid Use Among Patients Undergoing Implantation of Inflatable Penile ProsthesisMark E Ehlers, Charan S Mohan, Jason P Akerman, et al.
Urology|January 16, 2017
Detection of Upper Tract Urothelial Malignancies by Computed Tomography Urography in Patients Referred for Hematuria at a Large Tertiary Referral CenterClayton W Commander, David C Johnson, Mathew C Raynor, et al.
Gastrointestinal Cancer : Targets and Therapy|April 7, 2015
Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN lossAdam B Sendor, Kathryn E Hacker, Shufen Chen, et al.
The Journal of Biological Chemistry|July 30, 2013
Receptor tyrosine kinase-like orphan receptor 2 (Ror2) expression creates a poised state of Wnt signaling in renal cancerNeal R Rasmussen, Tricia M Wright, Samira A Brooks, et al.
The Journal of Biological Chemistry|August 17, 2016
Structure/Function Analysis of Recurrent Mutations in SETD2 Protein Reveals a Critical and Conserved Role for a SET Domain Residue in Maintaining Protein Stability and Histone H3 Lys-36 TrimethylationKathryn E Hacker, Catherine C Fahey, Stephen A Shinsky, et al.
Pageof 2